360 related articles for article (PubMed ID: 17521944)
41. Current issues in transfusion medicine in Norway.
Flesland O; Seghatchian J
Transfus Apher Sci; 2005 Feb; 32(1):7-10. PubMed ID: 15737866
[TBL] [Abstract][Full Text] [Related]
42. Blood banking and transfusion medicine for the apheresis medicine practitioner.
Jeffus S; Wehrli G
J Clin Apher; 2012; 27(3):160-7. PubMed ID: 22532095
[TBL] [Abstract][Full Text] [Related]
43. Recruitment of voluntary non-remunerated apheresis donors: the second five years' experience in Shenzhen.
Kong LK; Zhu WG; Zhang H; Yu ZR; Zhou YY; Chen YK; Wang F; Liu Y; Sun FJ
Transfus Apher Sci; 2004 Apr; 30(2):101-4. PubMed ID: 15062746
[TBL] [Abstract][Full Text] [Related]
44. [Towards bacterial detection in labile blood products].
Morel P
Transfus Clin Biol; 2005 Jun; 12(2):215-20. PubMed ID: 15894499
[TBL] [Abstract][Full Text] [Related]
45. The selection of donors in multicomponent collection management.
Bonomo P; Garozzo G; Bennardello F
Transfus Apher Sci; 2004 Feb; 30(1):55-9. PubMed ID: 14746822
[TBL] [Abstract][Full Text] [Related]
46. Risk factors for acute, moderate to severe donor reactions associated with multicomponent apheresis collections.
Yuan S; Gornbein J; Smeltzer B; Ziman AF; Lu Q; Goldfinger D
Transfusion; 2008 Jun; 48(6):1213-9. PubMed ID: 18346014
[TBL] [Abstract][Full Text] [Related]
47. The technique of therapeutic apheresis. Removal of abnormal blood elements may succeed when all else fails.
McLeod BC
J Crit Illn; 1991 May; 6(5):487-95. PubMed ID: 10147917
[TBL] [Abstract][Full Text] [Related]
48. Apheresis activity in Spain: a survey of the Spanish Apheresis Group.
Lozano M; Cid J; Areal C; Romon I; Muncunill J;
Transfus Apher Sci; 2013 Dec; 49(3):560-4. PubMed ID: 24148714
[TBL] [Abstract][Full Text] [Related]
49. [Future and limits of immunohemotherapy. Great possibilities with apheresis].
Norda R; Lundkvist I; Söderström T
Lakartidningen; 1995 Jan; 92(3):155-60. PubMed ID: 7837849
[No Abstract] [Full Text] [Related]
50. [Therapeutic apheresis: selective methods].
Kes P; Basić-Jukić N; Jurić I; Ratković-Gusić I
Acta Med Croatica; 2008; 62 Suppl 1():49-59. PubMed ID: 18578333
[TBL] [Abstract][Full Text] [Related]
51. Prospective evaluation of double RBC collection using three different apheresis systems.
Picker SM; Radojska SM; Gathof BS
Transfus Apher Sci; 2006 Dec; 35(3):197-205. PubMed ID: 17097350
[TBL] [Abstract][Full Text] [Related]
52. [Therapeutic value of the cell separator. Review and case reports].
Rossi PL
Minerva Med; 1979 Apr; 70(18):1289-98. PubMed ID: 450268
[TBL] [Abstract][Full Text] [Related]
53. Apheresis practice patterns in the United States of America: Analysis of a market claims database.
Zantek ND; Martinez RJ; Johnson AD; Tholkes AJ; Shah S
J Clin Apher; 2021 Oct; 36(5):750-758. PubMed ID: 34252989
[TBL] [Abstract][Full Text] [Related]
54. [Second multicenter study of thrombocytapheresis using the Fresenius AS104 blood cell separator and ring study for quality control of cell counts. Members of the Preparative and Therapeutic Hemapheresis Section of DGTI].
Müller N; Kretschmer V; Neumann HJ; Schermuly L; Weisswange T
Beitr Infusionsther Transfusionsmed; 1994; 32():317-22. PubMed ID: 9480116
[TBL] [Abstract][Full Text] [Related]
55. Markers of platelet activation and apoptosis in platelet concentrates collected by apheresis.
Procházková R; Andrýs C; Hubácková L; Krejsek J
Transfus Apher Sci; 2007 Oct; 37(2):115-23. PubMed ID: 17945536
[TBL] [Abstract][Full Text] [Related]
56. Fresh-frozen plasma, pathogen-reduced single-donor plasma or bio-pharmaceutical plasma?
Hellstern P
Transfus Apher Sci; 2008 Aug; 39(1):69-74. PubMed ID: 18583192
[TBL] [Abstract][Full Text] [Related]
57. Therapeutic apheresis: treatment in search of a disease.
J Health Care Technol; 1985; 1(4):279-98. PubMed ID: 10274623
[TBL] [Abstract][Full Text] [Related]
58. [Comparative studies for optimizing the collection of blood components in a multiple bag system].
Taborski U; Müller N
Beitr Infusionsther; 1988; 21():87-90. PubMed ID: 2463021
[No Abstract] [Full Text] [Related]
59. Plasma for fractionation: safety and quality issues.
Farrugia A
Haemophilia; 2004 Jul; 10(4):334-40. PubMed ID: 15230946
[TBL] [Abstract][Full Text] [Related]
60. Blood component fractionation: manual versus automatic procedures.
Pasqualetti D; Ghirardini A; Cristina Arista M; Vaglio S; Fakeri A; Waldman AA; Girelli G
Transfus Apher Sci; 2004 Feb; 30(1):23-8. PubMed ID: 14746818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
